🔎 Trials Near Me

Akèy › Osteyosakòm › Alabama › Birmingham

Etid klinik pou Osteyosakòm nan Birmingham, AL

7 etid pou Osteyosakòm ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

Ap rekriteFaz 1/2
  • University of Alabama/Children's of Alabama, Birmingham
Jiska laj 26 · Tout sèks · Mizajou Sep 3, 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Ap rekriteFaz 1/2
  • University of Alabama/Children's of Alabama, Birmingham
Jiska laj 30 · Tout sèks · Mizajou Sep 3, 2026 · NCT06541262

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Children's Hospital of Alabama, Birmingham
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Ap rekriteFaz 3
  • Children's Hospital of Alabama, Birmingham
Jiska laj 50 · Tout sèks · Mizajou Aug 25, 2026 · NCT05235165

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Ap rekriteEtid obsèvasyon
  • Children's Hospital of Alabama, Birmingham
Tout laj · Tout sèks · Mizajou May 18, 2026 · NCT01790152

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Ap rekrite
  • University of Alabama at Birmingham, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Ap rekriteFaz 2
  • Children's Hospital of Alabama/UAB, Birmingham
18 Months – 40 Years · Tout sèks · Mizajou Aug 12, 2025 · NCT05135975

Etid Osteyosakòm nan lòt vil

Lòt etid nan Birmingham

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.